News Formal

EU fines US firm Illumina $475 million for jumping gun on buyout of cancer-screening company Grail

  • 📰 AP
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The European Union slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the EU's antitrust watchdog. Last year, the EU blocked the $7.1 billion merger on competition grounds.

The Kremlin spokesman says Russia considers plans by G7 nations to offer Ukraine security guarantees “extremely ill-judged and potentially very dangerous.”

Illumina is a major supplier of next-generation sequencing systems for genetic and genomic analysis, while Grail is a health company developing blood tests to try to catch cancer early.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 728. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し